Chemo Pharma Laboratories Ltd.
BSE: 506365 | Sector: Health care |
NSE: N.A. | ISIN Code: INE320M01019 |
BSE 00:00 | 08 Aug | 37.85 |
-0.15 (-0.39%) |
OPEN
38.00 |
HIGH
38.00 |
LOW
36.10 |
NSE 05:30 | 01 Jan | Chemo Pharma Laboratories Ltd |
OPEN | 38.00 |
PREVIOUS CLOSE | 38.00 |
VOLUME | 329 |
52-Week high | 49.45 |
52-Week low | 21.70 |
P/E | 199.21 |
Mkt Cap.(Rs cr) | 6 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Chemo Pharma Laboratories Ltd. (CHEMOPHARMALAB) - Peer Group
COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
Roopa Industries | 32.20 | -2.42 | 25.34 | 16.34 | 0.33 | 1.29 | 24.96 |
Concord Drugs | 27.15 | 3.82 | 23.73 | 15.46 | 0.03 | 1.82 | 14.92 |
Panjon | 13.76 | 4.72 | 21.33 | 1.63 | -4.15 | 0.00 | - |
Colinz Labs | 43.10 | 3.11 | 19.70 | 1.84 | 0.11 | 0.80 | 53.88 |
Earum Pharmaceu. | 3.01 | 1.69 | 18.57 | 4.28 | 0.36 | 0.97 | 3.10 |
Ortin Labs. | 22.50 | 0.45 | 18.29 | 13.16 | 0.44 | 0.00 | - |
Phaarmasia | 23.35 | -3.91 | 15.95 | 4.16 | -0.15 | 0.00 | - |
Ishita Drugs | 46.05 | -5.44 | 13.77 | 3.97 | 0.37 | 2.69 | 17.12 |
Parmax Pharma | 31.45 | 1.78 | 11.76 | 7.09 | -0.05 | 0.38 | 82.76 |
Veerhealth Care | 11.64 | -4.90 | 8.07 | 2.01 | -0.35 | 0.00 | - |
Beryl Drugs | 8.84 | 0.00 | 4.48 | 3.52 | -0.47 | 0.00 | - |
Unjha Formul. | 9.36 | -3.41 | 4.19 | 2.49 | 0.04 | 0.00 | - |
Hind.Bio Science | 3.99 | 1.27 | 4.09 | 0.27 | -0.03 | 0.00 | - |
Quick Links for Chemo Pharma Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices